Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

Eli Lilly announced a $27 billion investment to build four new U.S. manufacturing sites, bringing its total U.S. investments to over $50 billion.

The move, aligned with Trump’s reshoring policies, was unveiled at a Washington, D.C., event featuring Trump administration officials.

The sites will boost production of key drug ingredients, including those for its obesity and diabetes treatments Zepbound and Mounjaro, and create over 3,000 permanent jobs.

Eli Lilly also aims to expand beyond these drugs into cancer, Alzheimer’s, and other treatments, CNBC has reported.

The company opposes cheaper compounded versions of its drugs, emphasizing safety and regulatory concerns.

read more: https://www.cnbc.com/2025/02/26/eli-lilly-to-invest-27-billion-in-new-us-manufacturing.html

👍 Like this video if you support bringing more pharmaceutical manufacturing to the U.S.!

💬 Comment below—do you think Eli Lilly’s investment will lower drug prices, or is this just about profits?

🔗 Share this video to keep the conversation going on healthcare, jobs, and drug affordability.

💰 Want to support the channel? Hit the YouTube Thanks button! Your support helps us bring you the latest updates on healthcare and economic policies.

👉 Don’t forget to subscribe for more news on big pharma, medical breakthroughs, and job growth!

Links for B.C.

Visit My Website
https://bcbegley.com

Follow Me On Facebook
https://www.facebook.com/B.C.Begley

Subscribe To My Patreon
https://www.patreon.com/bcbegley

Watch Me On YouTube
https://www.youtube.com/channel/UCGoUf-QQTlTN-BIh3ERCE9A

Follow Me On Twitter
https://twitter.com/BC_News1

Watch Me On Rumble
https://rumble.com/c/c-280191

Follow Me On Gab
https://gab.com/BC_Begley

Follow Me On Truth Social
https://truthsocial.com/@BC_Begley

Follow Me On BlueSky
https://bsky.app/profile/bcbegley.bsky.social

#EliLilly #Pharma #USManufacturing